Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
23.2M
-
Shares change
-
+9.48M
-
Total reported value, excl. options
-
$7.81M
-
Value change
-
+$3.18M
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$0.34
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q2 2024
13 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q2 2024.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.2M shares
of 27.6M outstanding shares and own 84.19% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (13.8M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.11M shares), JOHNSON & JOHNSON (1.92M shares), 8VC GP I, LLC (1.09M shares), BARCLAYS PLC (250K shares), UBS Group AG (48.8K shares), RENAISSANCE TECHNOLOGIES LLC (22.8K shares), XTX Topco Ltd (20.8K shares), Raymond James Financial Services Advisors, Inc. (10K shares), and PNC Financial Services Group, Inc. (4K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.